Loading company details...
Beta
Latest Form 4 (Oct 7, 2026): Hyong Kim (Chief Medical Officer): Sale of 32,479 shares, $269.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Hyong Kim, Chief Medical Officer | Sale | 32,479 | $269.6K |
| Sep 18, 2026 | Joseph S. Konowiecki, EVP, Corporate Affairs | Sale | 23,511 | $202.4K |
| Sep 16, 2026 | John E. Kao, Chief Executive Officer | Sale | 27,400 | $356.2K |
| Sep 12, 2026 | Dawn Christine Maroney, President | Sale | 122,707 | $1.56M |
| Sep 12, 2026 | John E. Kao, Chief Executive Officer | Sale | 172,600 | $2.24M |
| Aug 18, 2026 | Dawn Christine Maroney, President | Sale | 5,000 | $70.0K |
| Aug 10, 2026 | John E. Kao, Chief Executive Officer | Sale | 298,000 | $4.14M |
| Jul 16, 2026 | Dawn Christine Maroney, President | Exercise/Conversion | 152,068 | $1.38M |
| Jul 14, 2026 | John E. Kao, Chief Executive Officer | Sale | 279,644 | $5.54M |
| Jul 2, 2026 | Shane J. Hochradel, Chief Operations Officer | Grant/Award | 87,719 | n/a |